Anzeige
Mehr »
Sonntag, 08.02.2026 - Börsentäglich über 12.000 News
Der Shakeout: Silber hat genau das getan, was echte Bullenmärkte immer tun - es hat die Touristen abgeschüttelt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2P5V2 | ISIN: SE0005454873 | Ticker-Symbol: 4YD
Frankfurt
06.02.26 | 08:09
0,035 Euro
0,00 % 0,000
Branche
Nanotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
NANOLOGICA AB Chart 1 Jahr
5-Tage-Chart
NANOLOGICA AB 5-Tage-Chart

Aktuelle News zur NANOLOGICA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
NANOLOGICA Aktie jetzt für 0€ handeln
MoFlerie AB: Flerie's portfolio company Nanologica acquires Syntagon317Flerie AB (publ)'s portfolio company Nanologica has acquired Ardena Södertälje AB ('Syntagon'), a contract manufacturer with 45 employees. The acquisition strengthens Nanologica's production capacity...
► Artikel lesen
30.01.Ardena Completes Divestment of Sweden Drug Substance Site to Nanologica2
30.01.Nanologica AB: Nanologica Carries Out Directed Share Issues Of Approx. Sek 13.7 Million In Total, And A Fully Secured Rights Issue Of Approx. Sek 82.5 Million822NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA...
► Artikel lesen
29.01.Ardena Holding NV.: Ardena completes divestment of its Södertälje drug substance site in Sweden to Nanologica504Ghent, Belgium, 29th January 2026 - Ardena, a specialist CDMO and bioanalytical CRO enabling precision medicines and other complex therapies, today announced that it has completed the divestment of...
► Artikel lesen
23.10.25Nanologica AB: Interim Report Q3 2025 Nanologica AB (publ)570FINANCIAL SUMMARY Net sales for the third quarter amounted to SEK 2,843 thousand (611) and for the nine-month period to SEK 15,930 thousand (7,822)Operating loss for the quarter amounted to SEK -10...
► Artikel lesen
22.10.25Nanologica AB: Nanologica AB (publ) Receives Order of appx. SEK 1 Million In China364Nanologica has received an order for the company's silica-based purification media NLAB Saga® from a new distribution partner in China. The order relates to sampling NLAB Saga® to pharmaceutical manufacturers. "This...
► Artikel lesen
01.10.25Nanologica AB: Nanologica AB (publ) Enters the Insulin Market in China309Nanologica has entered the insulin market in China with an order of approximately SEK 2 million for the company's silica-based purification media NLAB Saga®. The customer is an insulin manufacturer...
► Artikel lesen
16.07.25The observation status for Nanologica AB (publ) is removed857On May 23, 2025, the shares in Nanologica AB (publ) were given observation status with reference to a public takeover offer from Flerie Invest AB to the shareholders in Nanologica AB (publ). Today...
► Artikel lesen
16.07.25Flerie AB: Flerie AB's subsidiary Flerie Invest AB announces final outcome of the mandatory cash offer to the shareholders of Nanologica AB (publ)639THIS PRESS RELEASE MAY NOT, DIRECTLY OR INDIRECTLY, BE DISTRIBUTED OR PUBLISHED IN OR INTO ANY JURISDICTION (INCLUDING WITHOUT LIMITATION AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE...
► Artikel lesen
10.07.25Nanologica AB: Interim Report Q2 2025 Nanologica AB (publ)622FINANCIAL SUMMARY Net sales for the second quarter amounted to SEK 2,335 thousand (2,174) and for the first half of the year to SEK 13,087 thousand (7,211)Operating loss for the quarter amounted to...
► Artikel lesen
13.06.25Nanologica AB: Statement From The Board Of Directors Of Nanologica AB (publ) Regarding The Mandatory Bid From Flerie Invest Ab698The Board of Directors of Nanologica AB (publ) ("Nanologica" or the "Company") unanimously recommends the shareholders of Nanologica not to accept the mandatory cash offer made by Flerie Invest AB ("Flerie")...
► Artikel lesen
12.06.25Flerie AB: Flerie's portfolio company Nanologica has received its first U.S. order864Stockholm, Sweden, June 12, 2025. Flerie AB's (publ) portfolio company Nanologica has announced that the company has secured an order for its silica-based purification media, NLAB Saga®, from a new...
► Artikel lesen
23.05.25Nanologica AB (publ) ges observationsstatus / Nanologica AB (publ) receives observation status1.325Idag, den 23 maj 2025, offentliggjorde Flerie Invest AB ett budpliktsbud till övriga aktieägare i Nanologica AB (publ). Enligt regelverket för Nasdaq Stockholm kan en emittent ges observationsstatus...
► Artikel lesen
23.05.25Nanologica AB: Comment from the Board of Nanologica AB (publ) Regarding the Mandatory Bid from Flerie Invest AB1.013Nanologica AB's (publ) ("Nanologica") main owner Flerie Invest AB ("Flerie") has today, May 23, 2025, made a mandatory cash offer of SEK 1.00 per share to the shareholders of Nanologica (the "Offer")....
► Artikel lesen
23.05.25Flerie AB: Flerie Invest AB announces a mandatory cash offer to the shareholders of Nanologica AB (publ)1.025THIS PRESS RELEASE MAY NOT, DIRECTLY OR INDIRECTLY, BE DISTRIBUTED OR PUBLISHED IN OR INTO ANY JURISDICTION (INCLUDING WITHOUT LIMITATION AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE...
► Artikel lesen
22.05.25Nanologica AB: Bulletin from the AGM 2025 Nanologica AB (publ)1.020Nanologica AB (publ) today May 22, 2025 held its Annual General Meeting in Stockholm, at which the following resolutions were adopted. Adoption of the income statement and balance sheet, disposition...
► Artikel lesen
26.04.25Nanologica AB: Nanologica AB Informs that Flerie Invest AB has Passed the Threshold for Mandatory Bid951Nanologica's main owner Flerie Invest AB ("Flerie") has acquired additional shares in Nanologica AB with the result that a mandatory bid obligation has arisen. Flerie's total holding in Nanologica after...
► Artikel lesen
16.04.25Nanologica AB: Interim Report Q1 2025 Nanologica AB (publ)940FINANCIAL SUMMARY Net sales for the first quarter amounted to SEK 10,751 thousand (5,037)The operating loss amounted to SEK 9,241 thousand (15,331)Loss after tax amounted to SEK 10,171 thousand (16...
► Artikel lesen
24.03.25Nanologica AB: Nanologica AB Extends Existing Loan from Flerie1.314Nanologica has extended the existing loan from Flerie Invest AB. The end date for the loan has been extended to July 2, 2027 from previous July 5, 2025. The loan will be paid off in stages according...
► Artikel lesen
14.02.25Nanologica AB: Year-End Report 2024 Nanologica AB (publ)892FINANCIAL SUMMARY • Net sales for the fourth quarter amounted to SEK 6,715 thousand (75) and for the full year to SEK 14,538 thousand (1,443) • Operating loss for the quarter amounted to SEK -11,890...
► Artikel lesen
20 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1